966 results on '"Hansen, John Bjarne"'
Search Results
2. Comparison of assays measuring extracellular vesicle tissue factor in plasma samples: communication from the ISTH SSC Subcommittee on Vascular Biology
3. Transcriptome-wide association study and Mendelian randomization in pancreatic cancer identifies susceptibility genes and causal relationships with type 2 diabetes and venous thromboembolism
4. Optimized workflow to modify microRNA expression in primary human intravascular cells
5. A genetic association study of circulating coagulation factor VIII and von Willebrand factor levels
6. The fatty liver index and risk of incident venous thromboembolism: the Tromsø Study
7. Extracellular vesicles from activated platelets possess a phospholipid-rich biomolecular profile and enhance prothrombinase activity
8. High microRNA-145 plasma levels are associated with decreased risk of future incident venous thromboembolism: the HUNT study
9. Joint effect of ischemic stroke and obesity on the risk of venous thromboembolism: the Tromsø Study
10. Proportion of venous thromboembolism attributed to recognized prothrombotic genotypes in men and women
11. Hemostatic factors, inflammatory markers, and risk of incident venous thromboembolism: The Multi‐Ethnic Study of Atherosclerosis
12. Combined effect of high factor VIII levels and high mean platelet volume on the risk of future incident venous thromboembolism
13. Plasma levels of P-selectin and future risk of incident venous thromboembolism
14. Survival after cancer-related venous thrombosis: the Scandinavian Thrombosis and Cancer Study
15. Hand grip strength in venous thromboembolism: risk of recurrence and mortality
16. Low D-dimer levels at diagnosis of venous thromboembolism are associated with reduced risk of recurrence: data from the TROLL registry
17. High plasma levels of C1-inhibitor are associated with lower risk of future venous thromboembolism
18. Fibrinogen gamma gene rs2066865 and risk of cancer-related venous thromboembolism
19. C1 inhibitor deficiency enhances contact pathway–mediated activation of coagulation and venous thrombosis
20. Venous thromboembolism and risk of depression: a population-based cohort study
21. Redefining clinical venous thromboembolism phenotypes: a novel approach using latent class analysis
22. Impact of the von Willebrand factor-ADAMTS-13 axis on the risk of future venous thromboembolism
23. A large‐scale exome array analysis of venous thromboembolism
24. Identification of Common and Rare Genetic Variation Associated With Plasma Protein Levels Using Whole-Exome Sequencing and Mass Spectrometry
25. Risk factors and predictors for venous thromboembolism in people with ischemic stroke: A systematic review
26. Joint effect of myocardial infarction and obesity on the risk of venous thromboembolism: The Tromsø Study
27. Elevated plasma levels of plasminogen activator inhibitor‐1 are associated with risk of future incident venous thromboembolism
28. Multi‐phenotype analyses of hemostatic traits with cardiovascular events reveal novel genetic associations
29. Plasma levels of platelet‐derived microvesicles are associated with risk of future venous thromboembolism
30. Rosuvastatin treatment decreases plasma procoagulant phospholipid activity after a VTE: A randomized controlled trial
31. A rapid, sensitive, and specific assay to measure TF activity based on chromogenic determination of thrombin generation
32. Estimated lifetime risk of venous thromboembolism in men and women in a Danish nationwide cohort: impact of competing risk of death
33. Plasma procoagulant phospholipid clotting time and venous thromboembolism risk
34. Socioeconomic status and risk of incident venous thromboembolism
35. Association of Traditional Cardiovascular Risk Factors With Venous Thromboembolism
36. Plasma levels of von Willebrand factor and future risk of incident venous thromboembolism
37. Combined effects of five prothrombotic genotypes and cancer on the risk of a first venous thromboembolic event
38. Atrial fibrillation, venous thromboembolism, ischemic stroke, and all‐cause mortality: The Tromsø study
39. Myocardial infarction, prothrombotic genotypes, and venous thrombosis risk: The Tromsø Study
40. Impact of respiratory symptoms and oxygen saturation on the risk of incident venous thromboembolism—the Tromsø study
41. Galectin-3-binding protein and future venous thromboembolism
42. Joint effects of cancer and variants in the factor 5 gene on the risk of venous thromboembolism
43. Associations Between Common and Rare Exonic Genetic Variants and Serum Levels of 20 Cardiovascular-Related Proteins
44. Associations Between Common and Rare Exonic Genetic Variants and Serum Levels of 20 Cardiovascular-Related Proteins: The Tromsø Study.
45. Cardiorespiratory fitness and future risk of venous thromboembolism
46. Consanguinity and rare mutations outside of MCCC genes underlie nonspecific phenotypes of MCCD
47. Effective filtering strategies to improve data quality from population-based whole exome sequencing studies
48. Corrigendum to ‘Hand grip strength and risk of incident venous thromboembolism: The Tromsø study’: [Res Pract Thromb Haemost. 2022 Nov 4;6/7 e12833]
49. Genomic and transcriptomic association studies identify 16 novel susceptibility loci for venous thromboembolism
50. Plasma levels of mannose‐binding lectin and future risk of venous thromboembolism
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.